Ad36 adipogenic adenovirus in human non-alcoholic fatty liver disease

Liver International

Volumn 30, Issue 2, 2010, Pages 184-190

  Trovato, Guglielmo M ^a   Martines, Giuseppe Fabio ^a   Garozzo, Adriana ^a   Tonzuso, Antonia ^a   Timpanaro, Rossella ^a   Pirri, Clara ^a   Trovato, Francesca M ^a   Catalano, Daniela ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Ad36; Adenovirus; Insulin resistance; NAFLD; Ultrasound

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; VIRUS ANTIBODY;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HOMEOSTASIS; HUMAN; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS 36; HUMAN ADENOVIRUS INFECTION; HUMAN CELL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OBESITY; SCORING SYSTEM; SERODIAGNOSIS;

ADENOVIRUS INFECTIONS, HUMAN; ADENOVIRUSES, HUMAN; ADIPOGENESIS; ANTIBODIES, VIRAL; BODY MASS INDEX; COMORBIDITY; FATTY LIVER; FEMALE; HUMANS; INSULIN RESISTANCE; ITALY; MALE; MIDDLE AGED; OBESITY; SEROEPIDEMIOLOGIC STUDIES;

EID: 77950606734     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2009.02127.x     Document Type: Article

References (27)

1. Torres DM, Harrison SA. Diagnosis and therapy of nonalcoholic steatohepatitis. Gastroenterology 2008, 134:1682-98.
2. Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Current concepts in the pathogenesis of nonalcoholic fatty liver disease. Liver Int 2007, 27:423-33.
3. Catalano D, Trovato GM, Martines GF, Randazzo M, Tonzuso A. Bright liver, body composition and insulin resistance changes with nutritional intervention: a follow-up study. Liver Int 2008, 28:1280-7.
4. Goessling W, Massaro JM, Vasan RS. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology 2008, 135:1935-44.
5. Riquelme A, Arrese M, Soza A. Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics. Liver Int 2009, 29:82-8.
6. Mathiesen UL, Franzén LE, Aselius H. Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002, 34:516-22.
7. Ratziu V, Charlotte F, Heurtier A. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005, 128:1898-906.
8. Saadeh S, Younossi ZM, Remer EM. The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002, 123:745-50.
9. Atkinson RL. Could viruses contribute to the worldwide epidemic of obesity? Int J Pediatr Obes 2008, 3((Suppl. 1)):37-43.
10. Atkinson RL, Dhurandhar NV, Allison DB. Human adenovirus-36 is associated with increased body weight and paradoxical reduction of serum lipids. Int J Obes 2005, 29:281-6.
11. Greenway F. Virus-induced obesity. Am J Physiol Regul Integr Comp Physiol 2006, 290:R188-9.
12. Rogers PM, Mashtalir N, Rathod MA. Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. Diabetes 2008, 57:2321-31.
13. Whigham LD, Israel BA, Atkinson RL. Adipogenic potential of multiple human adenoviruses in vivo and in vitro in animals. Am J Physiol Regul Integr Comp Physiol 2006, 290:R190-4.
14. Pasarica M, Loiler S, Dhurandhar NV. Acute effect of infection by adipogenic human adenovirus Ad36. Arch Virol 2008, 153:2097-102.
15. Chintakuntlawar AV, Astley R, Chodosh J. Adenovirus type 37 keratitis in the C57BL/6J mouse. Invest Ophthalmol Vis Sci 2007, 48:781-8.
16. Eguchi Y, Mizuta T, Ishibashi E. Hepatitis C virus infection enhances insulin resistance induced by visceral fat accumulation. Liver Int 2009, 29:213-20.
17. Leite NC, Salles GF, Araujo AL, Villela-Nogueira CA, Cardoso CR. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus. Liver Int 2009, 29:113-9.
18. Prati D, Taioli E, Zanella A. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med 2002, 137:1-10.
19. Matthews DR, Hosker JP, Rudenski AS. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-9.
20. Rutter MK, Wilson PW, Sullivan LM. Use of alternative thresholds defining insulin resistance to predict incident type 2 diabetes mellitus and cardiovascular disease. Circulation 2008, 117:1003-9.
21. Palmentieri B, de Sio I, La Mura V. The role of bright liver echo pattern on ultrasound B-mode examination in the diagnosis of liver steatosis. Dig Liver Dis 2006, 38:485-9.
22. Abonyo BO, Alexander MS, Heiman AS. Autoregulation of CCL26 synthesis and secretion in A549 cells: a possible mechanism by which alveolar epithelial cells modulate airway inflammation. Am J Physiol Lung Cell Mol Physiol 2005, 289:L478-88.
23. Preiss D, Sattar N. Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci 2008, 115:141-50.
24. Méndez-Sánchez N, Arrese M, Zamora-Valdés D, Uribe M. Treating nonalcoholic fatty liver disease. Liver Int 2007, 27:1157-65.
25. Baumeister SE, Völzke H, Marschall P. Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 2008, 134:85-94.
26. Allison DB, Downey M, Atkinson RL. Obesity as a disease: a white paper on evidence and arguments commissioned by the Council of the Obesity Society. Obesity 2008, 16:1161-77.
27. Fernández-Real JM, Ferri MJ, Vendrell J, Ricart W. Burden of infection and fat mass in healthy middle-aged men. Obesity 2007, 15:245-52.